Genomics BioSci & Tech. Revenue

In the year 2024, Genomics BioSci & Tech. had annual revenue of 482.75M TWD with 21.86% growth. Genomics BioSci & Tech. had revenue of 270.17M in the half year ending December 31, 2024, with 26.38% growth.

Revenue

482.75M

Revenue Growth

+21.86%

P/S Ratio

2.82

Revenue / Employee

n/a

Employees

n/a

Market Cap

1.36B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	482.75M	86.61M	21.86%
Dec 31, 2023	396.14M	-22.86M	-5.46%
Dec 31, 2022	419.00M	29.04M	7.45%
Dec 31, 2021	389.97M	-53.21M	-12.01%
Dec 31, 2020	443.18M	15.52M	3.63%
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Caliway Biopharmaceuticals	40.47M
PharmaEssentia	11.34B
Bora Pharmaceuticals Co., LTD.	20.87B
Lotus Pharmaceutical	19.12B
Polaris Group	87.67M
Oneness Biotech	117.33M
Center Laboratories	1.63B
Lumosa Therapeutics	43.59M

Revenue Rankings